Mariner, LLC Esperion Therapeutics, Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $3,975 - $7,412	4,141 Added 18.83%	26,130 $25,000
Q2 2023 Aug 11, 2023	BUY	$1.2 - $1.76 $26,386 - $38,700	21,989 New	21,989 $30,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $24,116 - $40,273	4,738 Added 36.31%	17,786 $111,000
Q3 2022 Nov 10, 2022	BUY	$5.45 - $8.13 $71,111 - $106,080	13,048 New	13,048 $87,000

209

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $140M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.